扶桑薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/11/15 | 1,895 | 1,902 | 1,892 | 1,896 | +5 | +0.3% | 24,200 |
2023/11/14 | 1,904 | 1,904 | 1,891 | 1,891 | -13 | -0.7% | 21,900 |
2023/11/13 | 1,897 | 1,916 | 1,889 | 1,904 | +5 | +0.3% | 25,100 |
2023/11/10 | 1,907 | 1,912 | 1,894 | 1,899 | -19 | -1% | 36,900 |
2023/11/09 | 1,909 | 1,924 | 1,903 | 1,918 | +9 | +0.5% | 23,000 |
2023/11/08 | 1,933 | 1,933 | 1,891 | 1,909 | -9 | -0.5% | 26,200 |
2023/11/07 | 1,922 | 1,939 | 1,916 | 1,918 | -11 | -0.6% | 16,500 |
2023/11/06 | 1,956 | 1,956 | 1,928 | 1,929 | -13 | -0.7% | 26,200 |
2023/11/02 | 1,940 | 1,942 | 1,921 | 1,942 | +5 | +0.3% | 22,900 |
2023/11/01 | 1,955 | 1,960 | 1,934 | 1,937 | -9 | -0.5% | 35,100 |
2023/10/31 | 1,920 | 1,946 | 1,912 | 1,946 | +24 | +1.2% | 20,800 |
2023/10/30 | 1,953 | 1,953 | 1,919 | 1,922 | -31 | -1.6% | 65,800 |
2023/10/27 | 1,950 | 1,958 | 1,944 | 1,953 | +13 | +0.7% | 21,200 |
2023/10/26 | 1,940 | 1,956 | 1,940 | 1,940 | +5 | +0.3% | 19,900 |
2023/10/25 | 1,949 | 1,950 | 1,934 | 1,935 | -2 | -0.1% | 20,100 |
2023/10/24 | 1,937 | 1,939 | 1,895 | 1,937 | +19 | +1% | 47,000 |
2023/10/23 | 1,933 | 1,943 | 1,918 | 1,918 | -12 | -0.6% | 31,200 |
2023/10/20 | 1,939 | 1,947 | 1,930 | 1,930 | -9 | -0.5% | 21,700 |
2023/10/19 | 1,944 | 1,955 | 1,936 | 1,939 | -9 | -0.5% | 23,200 |
2023/10/18 | 1,952 | 1,956 | 1,940 | 1,948 | -4 | -0.2% | 17,500 |
2023/10/17 | 1,953 | 1,963 | 1,946 | 1,952 | +28 | +1.5% | 21,700 |
2023/10/16 | 1,937 | 1,948 | 1,919 | 1,924 | -13 | -0.7% | 24,700 |
2023/10/13 | 1,960 | 1,960 | 1,929 | 1,937 | -23 | -1.2% | 21,800 |
2023/10/12 | 1,970 | 1,970 | 1,952 | 1,960 | -8 | -0.4% | 15,600 |
2023/10/11 | 1,970 | 1,970 | 1,954 | 1,968 | -2 | -0.1% | 17,000 |
2023/10/10 | 1,956 | 1,974 | 1,952 | 1,970 | +18 | +0.9% | 32,800 |
2023/10/06 | 1,924 | 1,963 | 1,924 | 1,952 | +28 | +1.5% | 29,100 |
2023/10/05 | 1,912 | 1,939 | 1,912 | 1,924 | +12 | +0.6% | 38,400 |
2023/10/04 | 1,922 | 1,937 | 1,906 | 1,912 | -19 | -1% | 67,500 |
2023/10/03 | 1,954 | 1,954 | 1,922 | 1,931 | -29 | -1.5% | 66,700 |
2023/10/02 | 1,972 | 1,981 | 1,954 | 1,960 | -11 | -0.6% | 46,700 |
2023/09/29 | 1,999 | 1,999 | 1,961 | 1,971 | -24 | -1.2% | 76,800 |
2023/09/28 | 1,998 | 2,005 | 1,989 | 1,995 | -31 | -1.5% | 43,300 |
2023/09/27 | 2,003 | 2,028 | 1,998 | 2,026 | +17 | +0.8% | 53,500 |
2023/09/26 | 2,020 | 2,020 | 2,006 | 2,009 | -12 | -0.6% | 78,600 |
2023/09/25 | 2,025 | 2,026 | 2,015 | 2,021 | +1 | ±0% | 41,200 |
2023/09/22 | 2,013 | 2,025 | 2,005 | 2,020 | -7 | -0.3% | 64,000 |
2023/09/21 | 2,031 | 2,033 | 2,012 | 2,027 | -8 | -0.4% | 113,800 |
2023/09/20 | 2,061 | 2,068 | 2,031 | 2,035 | -6 | -0.3% | 394,500 |
2023/09/19 | 2,039 | 2,045 | 2,030 | 2,041 | +2 | +0.1% | 114,500 |
2023/09/15 | 2,033 | 2,057 | 2,033 | 2,039 | +3 | +0.1% | 67,900 |
2023/09/14 | 2,052 | 2,069 | 2,031 | 2,036 | -12 | -0.6% | 74,700 |
2023/09/13 | 2,016 | 2,062 | 2,007 | 2,048 | -154 | -7% | 208,100 |
2023/09/12 | 2,182 | 2,202 | 2,177 | 2,202 | +23 | +1.1% | 9,700 |
2023/09/11 | 2,146 | 2,200 | 2,131 | 2,179 | +56 | +2.6% | 10,400 |
2023/09/08 | 2,154 | 2,193 | 2,123 | 2,123 | -40 | -1.8% | 16,100 |
2023/09/07 | 2,182 | 2,218 | 2,162 | 2,163 | -47 | -2.1% | 17,600 |
2023/09/06 | 2,214 | 2,219 | 2,165 | 2,210 | +96 | +4.5% | 31,800 |
2023/09/05 | 2,108 | 2,114 | 2,093 | 2,114 | +6 | +0.3% | 6,000 |
2023/09/04 | 2,079 | 2,108 | 2,073 | 2,108 | +40 | +1.9% | 7,800 |
251~
300
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「扶桑薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
扶桑薬 | 266,000円 | +8.3% | +98.1% | 3.08% | 8.74倍 | 0.60倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
ハートシード | 145,000円 | +154.1% | - | 0.00% | - | 7.10倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
ミズホメディ | 163,000円 | -5.1% | -21.2% | 4.91% | 10.29倍 | 1.96倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
セルソース | 111,700円 | -3.0% | -55.9% | 0.45% | 53.06倍 | 3.66倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
市場注目の銘柄
チャート関連のコラム